Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DAKOTA DRUG, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-30 to 2025-01-31
Current total value of award: $423.78
Description: 4567104983!NEOMYCIN-POLYMYXIN-HC EAR SUSP 10ML